|
Multimedia
Images, audio, and video related to cancer research
Calendar
Meetings, seminars, and press conferences focused on cancer research
Resources
Information on cancer types, treatment, prevention, and more
 Sponsored by:
The Cancer News Portal is supported by the National Cancer Institute of the National Institutes of Health. Additional information on cancer research, prevention, and treatment is available at www.cancer.gov |
Breaking News
Key: Meeting
Showing releases 51-75 out of 1207. << < 1 | 2 | 3 | 4 | 5 | 6 | 7 > >>
Public Release: 16-May-2013
 Journal of Cancer SurvivorshipCancer survivors battle with the blues Depressed cancer survivors are twice as likely to die prematurely than those who do not suffer from depression, irrespective of the cancer site. That's according to a new study, by Floortje Mols and colleagues, from Tilburg University in The Netherlands. Their work is published online in Springer's Journal of Cancer Survivorship. 
Netherlands Organization for Scientific Research, Dutch Cancer Society
Contact: Joan Robinson
Public Release: 16-May-2013
JAMA Otolaryngology - Head & Neck SurgeryStudy: Brain makes call on which ear is used for cell phone If you're a left-brain thinker, chances are you use your right hand to hold your cell phone up to your right ear, according to a newly published study from Henry Ford Hospital in Detroit. The study -- to appear online in JAMA Otolaryngology-Head & Neck Surgery -- shows a strong correlation between brain dominance and the ear used to listen to a cell phone.
Henry Ford Hospital
Contact: Krista Hopson
Public Release: 16-May-2013
BrainStudy brings greater understanding of tumor growth mechanism A study led by researchers from Plymouth University Peninsula Schools of Medicine and Dentistry has for the first time revealed how the loss of a particular tumor suppressing protein leads to the abnormal growth of tumors of the brain and nervous system. Contact: Andrew Gould
Public Release: 15-May-2013
2013 ASCO Annual MeetingPreclinical tests shows agent stops 'slippery' proteins from binding, causing Ewing sarcoma Continuous infusion of a novel agent not only halted the progression of Ewing sarcoma in rats, while some tumors also regressed to the point that cancer cells could not be detected microscopically. Researchers say the study provides preclinical evidence necessary to initiate a clinical trial.
NIH/National Cancer Institute
Contact: Karen Mallet
Public Release: 15-May-2013
2013 ASCO Annual MeetingFirst prospective trial shows molecular profiling timely for tailoring therapy CUSTOM is the first completed prospective clinical trial that used genetic analysis alone to assign cancer treatment for patients with one of three different cancers. Findings suggest patients, and their physicians, are eager to jump into next-era cancer care -- analysis of an individual's tumor to find and target genetic mutations that drive the cancer.
NIH/National Cancer Institute
Contact: Karen Mallet
Public Release: 15-May-2013
NeurologySkin cancer may be linked to lower risk of Alzheimer's disease People who have skin cancer may be less likely to develop Alzheimer's disease, according to new research published in the May 15, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology. The link does not apply to melanoma, a less common but more aggressive type of skin cancer. Contact: Rachel Seroka
Public Release: 15-May-2013
Health AffairsCancer diagnosis puts people at greater risk for bankruptcy People diagnosed with cancer are more than two-and-a-half times more likely to declare bankruptcy than those without cancer, according to a new study from Fred Hutchinson Cancer Research Center. Researchers also found that younger cancer patients had two- to five-fold higher bankruptcy rates compared to older patients, and that overall bankruptcy filings increased as time passed following diagnosis.
NIH/National Institute on Minority Health and Health Disparities
Contact: Dean Forbes
Public Release: 15-May-2013
Journal of Clinical InvestigationJCI early table of contents for May 15, 2013 This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published online, May 15, 2013, in the JCI: Hot on the TRAIL of graft vs. host disease; Researchers identify signals that direct the immune system to reject a transplanted organ; and many more. Contact: Jillian Hurst
Public Release: 15-May-2013
Journal of Clinical InvestigationHot on the TRAIL of graft vs. host disease In this issue of the Journal of Clinical Investigation, Arnab Ghosh and colleagues at Memorial Sloan-Kettering Cancer Center found that expression of a protein that causes cell death, TRAIL, in transplanted cells was critical for an effective anti-tumor response.
National Institutes of Health, US Department of Defense, Radiation Effects Research Foundation
Contact: Jillian Hurst
Public Release: 15-May-2013
2013 ASCO Annual MeetingExperts to present data addressing patient and physician barriers to clinical trials Researchers from University Hospitals Case Medical Center's Seidman Cancer Center will present findings from two studies evaluating new technologies designed to address common barriers to enrollment in clinical trials. Results from a large-scale, trial demonstrated that the use of tailored, web-based videos delivering educational information to patients before an oncologist visit can significantly improve knowledge and reduce attitudinal barriers that impact enrollment.
NIH/National Cancer Institute, NIH/National Center for Advancing Translational Sciences
Contact: Alicia Reale
Public Release: 15-May-2013
2013 ASCO Annual MeetingMayo Clinic: Scheduled imaging studies provide little help detecting relapse of aggressive lymphoma Imaging scans following treatment for diffuse large B-cell lymphoma do little to help detect a relapse, a Mayo Clinic study has found. The overwhelming majority of patients with this aggressive lymphoma already have symptoms, an abnormal physical exam or an abnormal blood test at the time of relapse, the researchers say. The findings will be presented at the American Society of Clinical Oncology annual meeting May 31-June 4 in Chicago.
National Institutes of Health, Mayo Clinic Center for the Science of Health Care Delivery
Contact: Joe Dangor
Public Release: 15-May-2013
2013 ASCO Annual MeetingPenn Medicine study finds broad support for rationing of some types of cancer care The majority of cancer doctors, patients, and members of the general public support cutting health care costs by refusing to pay for drugs that don't improve survival or quality of life, according to results of a new study that will be presented by researchers from the Perelman School of Medicine at the University of Pennsylvania during the annual meeting of the American Society of Clinical Oncology in Chicago in early June. Contact: Holly Auer
Public Release: 15-May-2013
Journal of General Internal MedicineDespite new recommendations, women in 40s continue to get routine mammograms at same rate Women in their 40s continue to undergo routine breast cancer screenings despite national guidelines recommending otherwise, according to new Johns Hopkins research. Contact: Stephanie Desmon
Public Release: 15-May-2013
2013 ASCO Annual MeetingPARP inhibitor shows activity in pancreatic, prostate cancers among patients carrying BRCA mutations In the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be effective against advanced pancreatic and prostate cancers. Results of the study, led by researchers from the Perelman School of Medicine at the University of Pennsylvania, will be presented during the American Society of Clinical Oncology's annual meeting in Chicago in early June. Contact: Holly Auer
Public Release: 14-May-2013
Clinical Breast CancerCognitive training improves executive function in breast cancer survivors Women whose breast cancer had been treated with chemotherapy demonstrated improved executive function, such as cognitive flexibility, verbal fluency and processing speed after using exercises developed by Lumosity, the leading online cognitive training program. The study also found significant improvement in self-reported measures of everyday executive function and observed some transfer to verbal memory.
NIH/National Institute of Health New Innovator Award
Contact: Erica Perng
Public Release: 14-May-2013
RadiologyDigital mammography cancer detection rates may vary significantly Digital direct radiography is significantly more effective than computed radiography at detecting breast cancer, according to a new study.
Canadian Institutes of Health Research
Contact: Linda Brooks
Public Release: 14-May-2013
Journal of General Internal MedicinePrimary care physicians vital to complete care of prostate cancer patients Androgen deprivation therapy is a common and effective treatment for advanced prostate cancer. Among other side-effects, it can cause bone thinning in men on long-term treatment. However, a new study finds that testing is not routine. The authors noted that men were more likely to be tested when they were being cared for by both a urologist and a primary care physician. Their paper appears in the Journal of General Internal Medicine, published by Springer.
NIH/National Cancer Institute, American Cancer Society
Contact: Joan Robinson
Public Release: 14-May-2013
Clinical Cancer ResearchNew drug enhances radiation treatment for brain cancer in preclinical studies A novel drug may help increase the effectiveness of radiation therapy for the most deadly form of brain cancer, report scientists at Virginia Commonwealth University Massey Cancer Center. In mouse models of human glioblastoma multiforme, the new drug helped significantly extend survival when used in combination with radiation therapy.
NIH/National Cancer Institute
Contact: John Wallace
Public Release: 14-May-2013
Journal of Health Care for the Poor and UnderservedNew BUSM study explores providers' perceptions of parental concerns about HPV vaccination A new Boston University School of Medicine study has found that low-income and minority parents may be more receptive to vaccinating their daughters against Human Papillomavirus, while white, middle-class parents are more likely to defer the vaccination. Contact: Gina Orlando
Public Release: 14-May-2013
CancerComorbidities should be factor in prostate biopsy choice, UCI study finds UC Irvine Health urologists and health policy experts report in a new study that two written assessments that identify existing comorbidities -- the patient-reported Total Illness Burden Index for Prostate Cancer and the physician-reported Charlson Comorbidity Index -- can successfully target prostate patients who would not benefit from biopsy to discover possible cancer. Contact: Tom Vasich
Public Release: 14-May-2013
Genes & DevelopmentStudy IDs key protein for cell death Findings may offer a new way to kill cancer cells by forcing them into an alternative programmed-death pathway.
National Institutes of Health, American Cancer Society
Contact: Sarah McDonnell
Public Release: 13-May-2013
NatureBreakthrough in how pancreatic cancer cells ingest nutrients points to new drug target In a landmark cancer study published online in Nature, researchers at NYU School of Medicine have unraveled a longstanding mystery about how pancreatic tumor cells feed themselves, opening up new therapeutic possibilities for a notoriously lethal disease with few treatment options. Pancreatic cancer kills nearly 38,000 Americans annually, making it a leading cause of cancer death. The life expectancy for most people diagnosed with it is less than a year. Contact: Christopher Rucas
Public Release: 13-May-2013
Cancer CellResearchers discover master regulator that drives majority of lymphoma A soon-to-be-tested class of drug inhibitors were predicted to help a limited number of patients with B-cell lymphomas with mutations affecting the EZH2 protein. However, a research team, led by investigators at Weill Cornell Medical College, now report that these agents may, in fact, help a much broader cross section of lymphoma patients.
Burroughs Wellcome Foundation & Chemotherapy Foundation, NIH/National Cancer Institute Physical Sciences
Contact: John Rodgers
Public Release: 13-May-2013
Proceedings of the National Academy of SciencesTumor-activated protein promotes cancer spread Researchers at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center report that cancers physically alter cells in the lymphatic system -- a network of vessels that transports and stores immune cells throughout the body -- to promote the spread of disease, a process called metastasis.
NIH/National Cancer Institute, National Institutes of Health, US Department of Defense
Contact: Scott LaFee
Public Release: 13-May-2013
LeukemiaLeap in leukemia treatment reported by Dartmouth researchers Doctors at Dartmouth-Hitchcock's Norris Cotton Cancer Center have found a combination of drugs to potentially treat chronic lymphocytic leukemia (CLL) more effectively. The research was published online on May 3, 2013, and it will appear as a letter in the journal Leukemia, a publication of the prestigious Nature Publishing Group. The study helps address a basic problem of treating CLL.
Leukemia and Lymphoma Society
Contact: Robin Dutcher
Showing releases 51-75 out of 1207. << < 1 | 2 | 3 | 4 | 5 | 6 | 7 > >>
|
Search News Releases
|
|||||||||||||||||||||||||
 |
||||
|
|
 |
|